methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-13-methoxycarbonyl-17-[[5-(pyrazine-2-carbonylamino)-1,3-dihydroisoindole-2-carbonyl]amino]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate

C60H69N9O10 — CID 155524205

IUPACmethyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-13-methoxycarbonyl-17-[[5-(pyrazine-2-carbonylamino)-1,3-dihydroisoindole-2-carbonyl]amino]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate
SMILESCC[C@]1(NC(=O)N2Cc3ccc(NC(=O)c4cnccn4)cc3C2)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
InChIInChI=1S/C60H69N9O10/c1-8-56(65-55(74)69-32-37-15-16-39(25-38(37)33-69)63-49(71)45-30-61-20-21-62-45)28-36-29-59(53(72)77-6,48-41(17-23-67(31-36)34-56)40-13-10-11-14-44(40)64-48)43-26-42-46(27-47(43)76-5)66(4)51-58(42)19-24-68-22-12-18-57(9-2,50(58)68)52(79-35(3)70)60(51,75)54(73)78-7/h10-16,18,20-21,25-27,30,36,50-52,64,75H,8-9,17,19,22-24,28-29,31-34H2,1-7H3,(H,63,71)(H,65,74)/t36-,50+,51-,52-,56+,57-,58-,59+,60+/m1/s1
InChIKeyJNIKDISCRLLJAE-JKQLJTASSA-N
MW1076.26 g/mol
LogP5.77
Rot. Bonds10

About methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-13-methoxycarbonyl-17-[[5-(pyrazine-2-carbonylamino)-1,3-dihydroisoindole-2-carbonyl]amino]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate

methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-13-methoxycarbonyl-17-[[5-(pyrazine-2-carbonylamino)-1,3-dihydroisoindole-2-carbonyl]amino]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate (PubChem CID 155524205) has the molecular formula C60H69N9O10 and a molecular weight of 1076.26 g/mol. Its IUPAC name is methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-13-methoxycarbonyl-17-[[5-(pyrazine-2-carbonylamino)-1,3-dihydroisoindole-2-carbonyl]amino]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate.

Molecular Properties

Compound Namemethyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-13-methoxycarbonyl-17-[[5-(pyrazine-2-carbonylamino)-1,3-dihydroisoindole-2-carbonyl]amino]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate
PubChem CID155524205
Molecular FormulaC60H69N9O10
Molecular Weight1076.26 g/mol
Exact Mass1075.52
IUPAC Namemethyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-13-methoxycarbonyl-17-[[5-(pyrazine-2-carbonylamino)-1,3-dihydroisoindole-2-carbonyl]amino]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate
SMILESCC[C@]1(NC(=O)N2Cc3ccc(NC(=O)c4cnccn4)cc3C2)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
InChIInChI=1S/C60H69N9O10/c1-8-56(65-55(74)69-32-37-15-16-39(25-38(37)33-69)63-49(71)45-30-61-20-21-62-45)28-36-29-59(53(72)77-6,48-41(17-23-67(31-36)34-56)40-13-10-11-14-44(40)64-48)43-26-42-46(27-47(43)76-5)66(4)51-58(42)19-24-68-22-12-18-57(9-2,50(58)68)52(79-35(3)70)60(51,75)54(73)78-7/h10-16,18,20-21,25-27,30,36,50-52,64,75H,8-9,17,19,22-24,28-29,31-34H2,1-7H3,(H,63,71)(H,65,74)/t36-,50+,51-,52-,56+,57-,58-,59+,60+/m1/s1
InChIKeyJNIKDISCRLLJAE-JKQLJTASSA-N
XLogP5.77
TPSA221.09 Ų
H-Bond Donors4
H-Bond Acceptors15
Rotatable Bonds10
Heavy Atoms79
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001076.26
LogP ≤ 55.77
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-13-methoxycarbonyl-17-[[5-(pyrazine-2-carbonylamino)-1,3-dihydroisoindole-2-carbonyl]amino]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-13-methoxycarbonyl-17-[[5-(pyrazine-2-carbonylamino)-1,3-dihydroisoindole-2-carbonyl]amino]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate?
The IUPAC name of methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-13-methoxycarbonyl-17-[[5-(pyrazine-2-carbonylamino)-1,3-dihydroisoindole-2-carbonyl]amino]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate (CID 155524205) is methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-13-methoxycarbonyl-17-[[5-(pyrazine-2-carbonylamino)-1,3-dihydroisoindole-2-carbonyl]amino]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate.
What is the SMILES notation for methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-13-methoxycarbonyl-17-[[5-(pyrazine-2-carbonylamino)-1,3-dihydroisoindole-2-carbonyl]amino]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate?
The canonical SMILES for methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-13-methoxycarbonyl-17-[[5-(pyrazine-2-carbonylamino)-1,3-dihydroisoindole-2-carbonyl]amino]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate is CC[C@]1(NC(=O)N2Cc3ccc(NC(=O)c4cnccn4)cc3C2)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.
What is the InChIKey of methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-13-methoxycarbonyl-17-[[5-(pyrazine-2-carbonylamino)-1,3-dihydroisoindole-2-carbonyl]amino]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate?
The InChIKey is JNIKDISCRLLJAE-JKQLJTASSA-N. The full InChI is InChI=1S/C60H69N9O10/c1-8-56(65-55(74)69-32-37-15-16-39(25-38(37)33-69)63-49(71)45-30-61-20-21-62-45)28-36-29-59(53(72)77-6,48-41(17-23-67(31-36)34-56)40-13-10-11-14-44(40)64-48)43-26-42-46(27-47(43)76-5)66(4)51-58(42)19-24-68-22-12-18-57(9-2,50(58)68)52(79-35(3)70)60(51,75)54(73)78-7/h10-16,18,20-21,25-27,30,36,50-52,64,75H,8-9,17,19,22-24,28-29,31-34H2,1-7H3,(H,63,71)(H,65,74)/t36-,50+,51-,52-,56+,57-,58-,59+,60+/m1/s1.
What are the key properties of methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-13-methoxycarbonyl-17-[[5-(pyrazine-2-carbonylamino)-1,3-dihydroisoindole-2-carbonyl]amino]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate?
methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-13-methoxycarbonyl-17-[[5-(pyrazine-2-carbonylamino)-1,3-dihydroisoindole-2-carbonyl]amino]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate has a molecular weight of 1076.26 g/mol, XLogP of 5.77, 10 rotatable bonds, 4 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-13-methoxycarbonyl-17-[[5-(pyrazine-2-carbonylamino)-1,3-dihydroisoindole-2-carbonyl]amino]-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate is sourced from PubChem (CID 155524205), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).